Alpine Global Management’s Clover Health Investments CLOV Stock Holding History

Alpine Global Management’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-143,712	Closed	-$453K	–	160
2024 Q4	$453K	Buy	+143,712	New	+$514K	0.06%	148
2023 Q1	–	Sell	-123,982	Closed	-$115K	–	208
2022 Q4	$115K	Buy	123,982 +107,194	+639%	+$143K	0.04%	203
2022 Q3	$29K	Sell	16,788 -45,887	-73%	-$120K	0.01%	157
2022 Q2	$134K	Buy	62,675 +7,481	+14%	+$19.9K	0.03%	138
2022 Q1	$196	Sell	55,194 -218,635	-80%	-$634K	0.04%	251
2021 Q4	$1.02M	Buy	+273,829	New	+$1.68M	0.15%	145
2021 Q1	–	Sell	-30,360	Closed	-$509K	–	325
2020 Q4	$509K	Buy	+30,360	New	+$338K	0.1%	102

Other funds holding CLOV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Alpine Global Management's CLOV Position: Q1 2025 in Review

Alpine Global Management sold out of Clover Health Investments (CLOV) in Q1 2025, closing a stake of 143,712 shares — an estimated $453K sold.

Alpine Global Management first reported a position in CLOV in Q4 2020 and held it in 7 quarters. The position peaked at $1.02M in Q4 2021. 202 funds tracked by Wall St. Rank hold CLOV as of Q1 2025.

Alpine Global Management reported no remaining Clover Health Investments position as of Q1 2025 after selling out during the quarter.
Alpine Global Management sold 143,712 Clover Health Investments shares in Q1 2025, an estimated $453K.
Alpine Global Management first reported a position in Clover Health Investments in Q4 2020 and held it in 7 quarters.
Alpine Global Management's Clover Health Investments position peaked at $1.02M in Q4 2021.
202 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2025.

Based on Alpine Global Management's 13F filing for Q1 2025, filed 15 May 2025.